Allergy Therapeutics logo

AGY - Allergy Therapeutics Share Price

12.75p 0.4  3.2%

Last Trade - 3:28pm

Sector
Healthcare
Size
Small Cap
Market Cap £78.6m
Enterprise Value £49.7m
Revenue £72.8m
Position in Universe 1043rd / 1830
Bullish
Bearish
Unlock AGY Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

AGY Revenue Unlock AGY Revenue

Net Income

AGY Net Income Unlock AGY Revenue

Normalised EPS

AGY Normalised EPS Unlock AGY Revenue

PE Ratio Range

AGY PE Ratio Range Unlock AGY Revenue

Dividend Yield Range

AGY Dividend Yield Range Unlock AGY Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
AGY EPS Forecasts Unlock AGY Revenue
Profile Summary

Allergy Therapeutics Plc is a pharmaceutical company. The Company focuses on the treatment and prevention of allergy with aluminum-free products. The Company's segments are Central Europe, which includes segments, such as Germany, Australia, Switzerland and the Netherlands; Southern Europe, which includes Italy and Spain; the United Kingdom, and Rest of World. The Company provides information to healthcare professionals about the prevention, diagnosis and treatment of allergic conditions with focus on allergy vaccination, which is also known as specific immunotherapy or desensitization therapy. The Company's products include Pollinex Trees, Pollinex Grasses+Rye, Skin Prick Testing and diagnostic products. Its vaccines trade under various brand names, such as Pollinex Quattro, Polligoid and TA Graser Top. It uses specialized systems to process the Tyrosine to form a suspension microcrystalline tyrosine (MCT) that is combined with some of its subcutaneous injected therapies.

Directors
Last Annual June 30th, 2018
Last Interim December 31st, 2018
Incorporated June 1, 2004
Public Since October 11, 2004
No. of Shareholders: n/a
No. of Employees: 499
Sector Healthcare
Industry Pharmaceuticals
Index FTSE Aim All Share ,
Exchange London Stock Exchange (AIM)
Shares in Issue 636,169,000
Free Float (0.0%)
Eligible for
ISAs
SIPPs
AGY Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for AGY
Upcoming Events for AGY
Wednesday 25th September, 2019
Full Year 2019 Allergy Therapeutics PLC Earnings Release
Similar to AGY
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.